GR3007402T3 - - Google Patents
Info
- Publication number
- GR3007402T3 GR3007402T3 GR930400553T GR930400553T GR3007402T3 GR 3007402 T3 GR3007402 T3 GR 3007402T3 GR 930400553 T GR930400553 T GR 930400553T GR 930400553 T GR930400553 T GR 930400553T GR 3007402 T3 GR3007402 T3 GR 3007402T3
- Authority
- GR
- Greece
- Prior art keywords
- quinoxalinones
- quinoxalinone
- alkoxyphenyl
- alkylphenyl
- bromophenyl
- Prior art date
Links
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical compound C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 abstract 1
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- 125000004799 bromophenyl group Chemical group 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000000068 chlorophenyl group Chemical group 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000004188 dichlorophenyl group Chemical group 0.000 abstract 1
- 125000001207 fluorophenyl group Chemical group 0.000 abstract 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1986/002335 WO1992005160A1 (en) | 1986-10-30 | 1986-10-30 | 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3007402T3 true GR3007402T3 (el) | 1993-07-30 |
Family
ID=22195697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR930400553T GR3007402T3 (el) | 1986-10-30 | 1993-03-18 |
Country Status (11)
Country | Link |
---|---|
US (1) | US4940708A (el) |
EP (1) | EP0266102B1 (el) |
JP (1) | JPS63295566A (el) |
AT (1) | ATE86985T1 (el) |
DE (1) | DE3784835T2 (el) |
DK (1) | DK561487A (el) |
ES (1) | ES2046206T3 (el) |
GR (1) | GR3007402T3 (el) |
IE (1) | IE68851B1 (el) |
PT (1) | PT85998B (el) |
WO (1) | WO1992005160A1 (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940708A (en) * | 1986-10-30 | 1990-07-10 | Pfizer Inc. | 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts |
US6369057B1 (en) | 1991-04-15 | 2002-04-09 | Aventis Pharma Deutschland Gmbh | Quinoxalines, processes for their preparation and their use |
DE59209965D1 (de) * | 1991-04-15 | 2002-10-17 | Aventis Pharma Gmbh | Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung |
US7351709B2 (en) | 2004-06-09 | 2008-04-01 | Wyeth | Estrogen receptor ligands |
EP1940805A4 (en) * | 2005-08-26 | 2009-11-11 | Methylgene Inc | BENZODIAZEPIN AND BENZOPIPERAZINANALOGA AS INHIBITORS OF HISTONDEACETYLASE |
MX2010011975A (es) | 2008-04-30 | 2011-01-21 | Xyleco Inc | Procesamiento de biomasa. |
US8236535B2 (en) | 2008-04-30 | 2012-08-07 | Xyleco, Inc. | Processing biomass |
US8212087B2 (en) | 2008-04-30 | 2012-07-03 | Xyleco, Inc. | Processing biomass |
US7867358B2 (en) | 2008-04-30 | 2011-01-11 | Xyleco, Inc. | Paper products and methods and systems for manufacturing such products |
MX343541B (es) | 2008-10-28 | 2016-11-09 | Xyleco Inc | Procesamiento de materiales. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
JPS5559314A (en) * | 1978-10-27 | 1980-05-02 | Sony Corp | Magnetic scale signal detector |
US4209527A (en) * | 1979-05-16 | 1980-06-24 | Pfizer Inc. | Benzimidazolone derivatives |
US4940708A (en) * | 1986-10-30 | 1990-07-10 | Pfizer Inc. | 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts |
-
1986
- 1986-10-30 US US07/424,298 patent/US4940708A/en not_active Expired - Fee Related
- 1986-10-30 WO PCT/US1986/002335 patent/WO1992005160A1/en unknown
-
1987
- 1987-01-27 IE IE287787A patent/IE68851B1/en not_active IP Right Cessation
- 1987-10-16 DE DE8787309160T patent/DE3784835T2/de not_active Expired - Fee Related
- 1987-10-16 EP EP87309160A patent/EP0266102B1/en not_active Expired - Lifetime
- 1987-10-16 ES ES198787309160T patent/ES2046206T3/es not_active Expired - Lifetime
- 1987-10-16 AT AT87309160T patent/ATE86985T1/de active
- 1987-10-22 JP JP62267597A patent/JPS63295566A/ja active Granted
- 1987-10-27 DK DK561487A patent/DK561487A/da not_active Application Discontinuation
- 1987-10-27 PT PT85998A patent/PT85998B/pt not_active IP Right Cessation
-
1993
- 1993-03-18 GR GR930400553T patent/GR3007402T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1992005160A1 (en) | 1992-04-02 |
JPH0536436B2 (el) | 1993-05-31 |
DK561487D0 (da) | 1987-10-27 |
IE68851B1 (en) | 1996-07-24 |
DE3784835D1 (de) | 1993-04-22 |
ES2046206T3 (es) | 1994-02-01 |
EP0266102A2 (en) | 1988-05-04 |
PT85998B (pt) | 1990-08-31 |
EP0266102A3 (en) | 1989-11-23 |
DE3784835T2 (de) | 1993-06-24 |
ATE86985T1 (de) | 1993-04-15 |
IE872877L (en) | 1988-04-28 |
JPS63295566A (ja) | 1988-12-01 |
PT85998A (en) | 1987-11-01 |
EP0266102B1 (en) | 1993-03-17 |
DK561487A (da) | 1988-08-08 |
US4940708A (en) | 1990-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4869690A (en) | Pyrazolopyridine compound and processes for preparation thereof | |
CA2223595A1 (en) | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues | |
YU46087B (sh) | Postupak za dobijanje analoga rebekamicina | |
NO903438D0 (no) | Fremgangsmaate for fremstilling av tiazolderivater. | |
GR3007402T3 (el) | ||
AU657106B2 (en) | Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents | |
ES2103931T3 (es) | Imidazoacridinas y su uso antineoplasico. | |
MY106552A (en) | Novel pyrido[2,3-f] [1,4]thiazepines and pyrido[3,2-b] [1,5] benzothiazepines. | |
WO1999004770A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
EP0285284A3 (en) | N-phenethylaminoalkyl-benzamide anti-arrhythmia agents | |
NO903211D0 (no) | Salter av n5,n10-metylen-5-6-7-8-tetrahydrofolsyre samt fremgangsmaate for deres fremstilling. | |
GR3005176T3 (el) | ||
AU1254188A (en) | Disaccharide derivatives | |
ES8704881A1 (es) | Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. | |
ES8800255A1 (es) | Procedimiento para preparar n6 -benzopirano- y benzotiopirano-adenosinas. | |
BE895712A (fr) | Derives de benzo-1,3-thiazine-1,1-dixoyde, leur preparation et leur utilisation | |
EP0176049A3 (en) | Aminoalkylnaphtalene derivatives having pharmacological activities | |
FI862634A0 (fi) | Spiro-heteroazaloner foer vaord av komplikationer vid diabetes. | |
DE3766028D1 (de) | 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester. | |
ES8602789A1 (es) | Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos | |
CA1270833C (en) | 2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS | |
EP0354539A3 (en) | Antiinflammatory carbinoloimidazoles |